Article Information
- Received June 30, 2004
- Revision received September 28, 2004
- Accepted September 28, 2004
- First published November 10, 2004.
- Version of record published November 10, 2004.
Author Information
- Wensheng Lin1,
- April Kemper3,
- Ken D. McCarthy4,
- Peter Pytel2,
- Jian-Ping Wang5,
- Iain L. Campbell6,
- Manuel F. Utset2, and
- Brian Popko1
- 1Jack Miller Center for Peripheral Neuropathy, Department of Neurology, and 2Department of Pathology, University of Chicago, Chicago, Illinois 60637, 3Neuroscience Center and 4Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, 5Division of Pharmacology, University of Missouri-Kansas City, Kansas City, Missouri 64108, and 6School of Molecular and Microbial Biosciences, The University of Sydney, Sydney, New South Wales 2006, Australia
Author contributions
Disclosures
- Received June 30, 2004.
- Revision received September 28, 2004.
- Accepted September 28, 2004.
This work was supported by National Institutes of Health Grants NS34939 (B.P.) and MH62231 (I.L.C.), by National Multiple Sclerosis Society Grant RG 3291 A4/T (B.P.), and by grants from the Schweppe Foundation, the Brain Research Foundation, and the Children's Brain Tumor Foundation to M.F.U. We acknowledge the helpful contribution of discussions with colleagues at the Myelin Repair Foundation.
Correspondence should be addressed to either of the following: Dr. Brian Popko, Jack Miller Center for Peripheral Neuropathy, Department of Neurology, University of Chicago, 5841 South Maryland Avenue, MC2030, Chicago, IL 60637, E-mail: bpopko{at}neurology.bsd.uchicago.edu; or Dr. Manuel F. Utset, Department of Pathology, University of Chicago, 924 East 57th Street, Chicago, IL 60637, E-mail: m-utset{at}uchicago.edu.
Copyright © 2004 Society for Neuroscience 0270-6474/04/2410074-10$15.00/0
Online Impact